Cambridge Healthtech Advisors

Cambridge Healthtech Advisors (CHA) is a specialized management consulting firm providing strategic advisory services to the life sciences, pharmaceutical, and healthcare industries. As the consulting arm of Cambridge Healthtech Institute (CHI), the firm leverages an extensive network of industry experts to deliver market analysis, technology assessment, and strategic planning. CHA assists clients in navigating complex regulatory environments, optimizing R&D portfolios, and identifying emerging market opportunities in areas such as diagnostics, drug discovery, and digital health. Following the acquisition of its parent company by Endeavor Business Media in 2022, CHA continues to provide data-driven insights to global biotech and pharma stakeholders. Their services are designed to bridge the gap between emerging technology and commercial success.